73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-
New study reveals an unexpected survival mechanism of a subset of cancer cells

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi

New study reveals an unexpected survival mechanism of a subset of cancer cells

by Instituto de Medicina MolecularMetaphase chromosomes from ALT cancer cells (U2OS osteosarcoma cell line) depleted for FANCM. Telomeric DNA is in green, chromosomal DNA is in red. The arrowheads poi
Artificial intelligence-aided colonoscopy does not increase cancer detection

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs
A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co
Startup to commercialize blood test for most major cancers

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou
Tracking the epigenetic evolution of a cancer, cell by cell

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables
Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc
Study reveals persistent cancer disparities in Appalachian Kentucky

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig
A new method for conducting a liquid biopsy for liver cancer

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the
Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot
Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre

Pancreatic cancer discovery reveals how the aggressive cancer fuels its growth

by University of VirginiaThe new discovery represents the fulfillment of years of work for David F. Kashatus, Ph.D., who first proposed the research project while interviewing at UVA in 2012. Cre
Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

by Victoria Warren,Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainAccording to the study "Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions"&

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

by Victoria Warren,Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainAccording to the study "Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions"&